awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33399656-3A1483F5-80BC-4FD4-A056-F248B0C2F00C
Q33399656-3A1483F5-80BC-4FD4-A056-F248B0C2F00C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399656-3A1483F5-80BC-4FD4-A056-F248B0C2F00C
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.
P2860
Q33399656-3A1483F5-80BC-4FD4-A056-F248B0C2F00C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399656-3A1483F5-80BC-4FD4-A056-F248B0C2F00C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9aa6bfa7a661a3877dda87219a770f28c4a4d464
P2860
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.